|
1.
|
|
12 p, 804.5 KB |
RIC versus MAC UCBT in adults with AML : A report from Eurocord, the ALWP and the CTIWP of the EBMT
/
Baron, Frédéric (University of Liege) ;
Ruggeri, Annalisa (Hôpital Saint-Antoine (Paris, França)) ;
Beohou, Eric (Hôpital Saint-Antoine (Paris, França)) ;
Labopin, Myriam (Hôpital Saint-Antoine (Paris, França)) ;
Sanz, Guillermo (Hospital Universitari i Politècnic La Fe (València)) ;
Milpied, Noel (University of Bordeaux) ;
Michallet, Mauricette (Centre Hospitalier de Lyon Sud) ;
Bacigalupo, Andrea (Ospedale San Martino) ;
Blaise, Didier (Aix-Marseille Université) ;
Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ;
Socié, Gérard (Hospital Saint-Louis) ;
Cornelissen, Jan J. (Erasmus Medical Center-Daniel den Hoed Cancer Center) ;
Schmid, Christoph (University of Munich) ;
Giebel, Sebastian (Gliwice Branch) ;
Gorin, Norbert-Claude (Hospital Saint Antoine) ;
Esteve, Jordi (Hematology. Hospital Clinic) ;
Ciceri, Fabio (Ospedale San Raffaele) ;
Savani, Bipin N. (Vanderbilt University Medical Center) ;
Mohty, Mohamad (UMRs 938) ;
Gluckman, Eliane (Centre Scientifique de Monaco) ;
Nagler, Arnon (The Chaim Sheba Medical Center) ;
Universitat Autònoma de Barcelona
Nonrelapse mortality (NRM) is the first cause of treatment failure after unrelated cord blood transplantation (UCBT) following myeloablative conditioning (MAC). In the last decade, reduced-intensity conditioning (RIC) regimens have been developed with the aim of reducing NRM and allowing older patients and those with medical comorbidities to benefit from UCBT. [...]
2016 -  10.18632/oncotarget.9599
Oncotarget, Vol. 7 Núm. 28 (2016) , p. 43027-43038
|
|
|
2.
|
|
7 p, 793.0 KB |
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation : A retrospective analysis of the EBMT chronic malignancies working party
/
Scheid, C. (University of Cologne) ;
De Wreede, L. (DKMS. German Bone Marrow Donor Center) ;
Van Biezen, A. (Leiden University Medical Center) ;
Koenecke, C. (Hannover Medical School) ;
Göhring, G. (Hannover Medical School) ;
Volin, L. (HUCH Comprehensive Cancer Center) ;
Maertens, J. (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Finke, J. (University of Freiburg) ;
Passweg, J. (University Hospital) ;
Beelen, D. (University Hospital) ;
Cornelissen, J. J. (University Medical Center Rotterdam) ;
Itälä-Remes, M. (Turku University Hospital (Finlàndia)) ;
Chevallier, P. (CHU Nantes) ;
Russell, N. (Nottingham University) ;
Petersen, E. (University Medical Centre) ;
Milpied, N. (Hôpital Haut-leveque) ;
Richard Espiga, C. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Peniket, A. (Churchill Hospital) ;
Sierra Llopart, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Mufti, G. (GKT School of Medicine) ;
Crawley, C. (Addenbrookes Hospital (Cambridge, Regne Unit)) ;
Veelken, J.H. (Leiden University Hospital) ;
Ljungman, P. (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Cahn, Jean-Yves (Hopital A. Michallon) ;
Alessandrino, E.P. (Fondazione IRCCS Policlinico San Matteo) ;
De Witte, T. (Radboud University-Nijmegen Medical Centre) ;
Robin, M. (Hopital St. Louis) ;
Kröger, N. (University Hospital Eppendorf) ;
Universitat Autònoma de Barcelona
The International Prognostic Scoring System has been revised (IPSS-R) to predict prognosis of patients with myelodysplastic syndromes at diagnosis. To validate the use of the IPSS-R assessed before transplant rather than at diagnosis we performed a retrospective analysis of the EBMT database. [...]
2017 - 10.1038/bmt.2017.171
Bone marrow transplantation, Vol. 52 Núm. 11 (january 2017) , p. 1519-1525
|
|
|
3.
|
|
11 p, 340.8 KB |
Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
/
Rafii, Hanadi (Centre Scientifique de Monaco) ;
Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milan, Itàlia)) ;
Kenzey, Chantal (Centre Scientifique de Monaco) ;
Sanz, Jaime (Hospital Universitari i Politècnic La Fe (València)) ;
Peffault De La Tour, Régis (Assistance Publique-Hôpitaux de Paris) ;
Esquirol, Albert (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Michel, Gérard (Hopital pédiatrique de la Timone (Marseille, França)) ;
Chevallier, Patrice (Hospital Hotel Dieu (Nantes, França)) ;
Rubio, Marie-Thérèse (CHRU Nancy (Nancy, França)) ;
Cornelissen, Jan J. (Erasmus MC-Daniel den Hoed Cancer Centre) ;
Michallet, Mauricette (Centre Leon Berard) ;
Volt, Fernanda (Monacord, Centre Scientifique de Monaco) ;
Rivera-Franco, Monica M. (Centre Scientifique de Monaco) ;
Scigliuolo, Graziana Maria (Centre Scientifique de Monaco) ;
Cappelli, Barbara (Centre Scientifique de Monaco) ;
Rocha, Vanderson (São Paulo Medical School) ;
Gluckman, Eliane (Centre Scientifique de Monaco) ;
Universitat Autònoma de Barcelona
Subsequent neoplasms (SNs) compromise long-term survivors after hematopoietic cell transplantation. We performed a retrospective analysis of SNs in 10 358 recipients of umbilical cord blood transplantation (UCBT) from 1988 to 2018. [...]
2022 - 10.1182/bloodadvances.2022007941
Blood advances, Vol. 7 (november 2022) , p. 1976-1986
|
|
|
4.
|
|
8 p, 732.8 KB |
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
/
Gagelmann, N. (University Medical Center Hamburg-Eppendorf) ;
Eikema, D. J. (EBMT Statistics) ;
Stelljes, M. (University of Münster) ;
Beelen, D. (University Hospital Essen (Alemanya)) ;
de Wreede, Liesbeth C (EBMT Statistics) ;
Mufti, G. (GKT School of Medicine) ;
Knelange, N. S. (EBMT Data Office) ;
Niederwieser, D. (University Hospital Leipzig) ;
Friis, L. S. (University of Copenhagen) ;
Ehninger, Gerhard (Universitätsklinikum Dresden) ;
Nagler, Arnon (Chaim Sheba Medical Center (Israel)) ;
Yakoub-Agha, Ibrahim (Université Lille2) ;
Meijer, E. (Amsterdam UMC. University Medical Center) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Maertens, Johan (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Kanz, L. (Universität Tübingen) ;
Lopez-Corral, L. (Hospital Clínico Universitario (Salamanca)) ;
Brecht, A. (Deutsche Klinik für Diagnostik) ;
Craddock, Charles (Centre for Clinical Haematology) ;
Finke, J. (University of Freiburg) ;
Cornelissen, J. J. (Erasmus MC Cancer Institute. Erasmus University Medical Center) ;
Bernasconi, P. (Fondazione IRCCS Policlinico San Matteo) ;
Chevallier, Patrice (CHU Nantes) ;
Sierra, Jorge (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Robin, M. (Hopital St. Louis) ;
Kroeger, Nicolaus (University Medical Center Hamburg-Eppendorf) ;
Universitat Autònoma de Barcelona
The aim of this study was to develop and validate a clinical and transplant-specific prognostic score using data from a large cohort of patients with myelodysplastic syndromes reported to the European Society for Blood and Marrow Transplantation registry. [...]
2019 - 10.3324/haematol.2018.200808
Haematologica, Vol. 104 Núm. 5 (30 2019) , p. 929-936
|
|
|
5.
|
|
13 p, 1.0 MB |
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia : A comparative study of the ALWP EBMT
/
Sanz, Jaime (Centro de Investigación Biomédica en Red de Cáncer) ;
Galimard, J. E. (EBMT Paris Office. Hospital Saint Antoine) ;
Labopin, Myriam (Department of Hematology. Hopital Saint Antoine. Sorbonne University) ;
Afanasyev, B. (First State Pavlov Medical University of St. Petersburg. Raisa Gorbacheva Mem. Research Institute for Paediatric Oncology. Hematology. and Transplantation) ;
Angelucci, Emanuele (Department of Haematology. IRCCS Ospedale Policlinico San Martino) ;
Ciceri, Fabio (Haematology and BMT) ;
Blaise, Didier (Programme de Transplantation and Therapie Cellulaire. Centre de Recherche en Cancérologie de Marseille. Institut Paoli Calmettes) ;
Cornelissen, J. J. (Department of Hematology. Erasmus MC Cancer Institute. University Medical Center Rotterdam) ;
Meijer, E. (Department of Hematology (Br 250). VU University Medical Center) ;
Diez-Martin, J. L. (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Koc, Y. (Stem Cell Transplant Unit. Medical Park Hospitals) ;
Rovira Tarrats, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Castagna, L. (Transplantation Unit. Department of Oncology and Haematology. Istituto Clinico Humanitas) ;
Savani, B. N. (Vanderbilt University Medical Center) ;
Ruggeri, Annalisa (Ospedale Pediatrico Bambino Gesù (Roma, Itàlia)) ;
Nagler, Arnon (ALWP of the EBMT Office. Saint Antoine Hospital) ;
Mohty, Mohamad (Department of Hematology. Hopital Saint Antoine. Sorbonne University) ;
Universitat Autònoma de Barcelona
Background: The use of post-transplant cyclophosphamide (PTCy) is highly effective in preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting and is being increasingly used in matched sibling (MSD) and matched unrelated (MUD) transplants. [...]
2020 - 10.1186/s13045-020-00882-6
Journal of hematology & oncology, Vol. 13 Núm. 1 (june 2020) , p. 46
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
